- Open Access
Rapid detection of Pseudomonas aeruginosa from positive blood cultures by quantitative PCR
© Cattoir et al; licensee BioMed Central Ltd. 2010
Received: 17 March 2010
Accepted: 4 August 2010
Published: 4 August 2010
Pseudomonas aeruginosa is responsible for numerous bloodstream infections associated with severe adverse outcomes in case of inappropriate initial antimicrobial therapy. The present study was aimed to develop a novel quantitative PCR (qPCR) assay, using ecfX as the specific target gene, for the rapid and accurate identification of P. aeruginosa from positive blood cultures (BCs).
Over the period August 2008 to June 2009, 100 BC bottles positive for gram-negative bacilli were tested in order to evaluate performances of the qPCR technique with conventional methods as gold standard (i.e. culture and phenotypic identification).
Thirty-three strains of P. aeruginosa, 53 strains of Enterobactericaeae, nine strains of Stenotrophomonas maltophilia and two other gram-negative species were isolated while 3 BCs were polymicrobial including one mixture containing P. aeruginosa. All P. aeruginosa clinical isolates were detected by qPCR except a single strain in mixed culture. Performances of the qPCR technique were: specificity, 100%; positive predictive value, 100%; negative predictive value, 98.5%; and sensitivity, 97%.
This reliable technique may offer a rapid (<1.5 h) tool that would help clinicians to initiate an appropriate treatment earlier. Further investigations are needed to assess the clinical benefit of this novel strategy as compared to phenotypic methods.
Pseudomonas aeruginosa is a major human opportunistic pathogen responsible for numerous nosocomial infections, especially within intensive care units . In US hospital settings, P. aeruginosa is the seventh (i.e. 4.3%) most frequently isolated pathogen from the bloodstream, with a crude mortality exceeding 25% . Although rarely responsible for community-acquired infections, P. aeruginosa represents 6.8% of bacteremia caused by gram-negative rods . Since P. aeruginosa bacteremia is clinically indistinguishable from other gram-negative bacterial bloodstream infections, it has been demonstrated that an inappropriate initial antimicrobial therapy was associated with severe adverse outcomes [4–6].
Because standard phenotypic methods are time consuming and most have inherent limitations, molecular techniques have shown to be a rapid and reliable approach for the identification of bacterial pathogens . Therefore, several PCR-based methods have already been described to identify P. aeruginosa, especially in respiratory samples from cystic fibrosis patients. Different molecular targets have been employed such as 16 S rRNA, algD, oprI, oprL, toxA, gyrB, and ecfX genes [8–13]. Since false-positive results (with 16 S rRNA and oprI genes) as well as false-negative results (with algD and toxA genes) have been reported, the ecfX gene is a suitable target for species-specific identification of P. aeruginosa isolates [11, 13].
While identification of P. aeruginosa from a positive blood culture (BC) takes at least 24 h using conventional techniques, molecular identification directly from positive BCs could be an interesting alternative leading to a rapid and accurate species-level identification with subsequent adequate empirical treatment. However, PCR detection of P. aeruginosa from positive BCs has been poorly investigated [14, 15], and the authors used oprI and oprL as target genes, described previously as non-100% specific [8, 11].
In this study, we have developed a novel quantitative PCR (qPCR) assay, using ecfX as the specific target gene, for the rapid and accurate identification of P. aeruginosa from positive BCs
Clinical specimens and phenotypic identification
From August 2008 to June 2009, a total of 100 positive BCs from 100 inpatients were included. For each patient, a pair of aerobic (BacT/ALERT FA) and anaerobic (BacT/ALERT FN) bottles was taken, then incubated in the BacT/ALERT automated continuous monitoring system (bioMérieux, Marcy-l'Etoile, France). The distribution of positive BCs by bottle type was as follows: 87 aerobic (87%) and 13 (13%) anaerobic. All these BCs showed gram-negative rods at the direct examination, and most of them presented a Gram-staining and/or a motility compatible with those of the species P. aeruginosa. Positive bottles were inoculated aerobically and anaerobically at 37°C for 24-48 h onto trypticase-soy agar, Drigalski agar, 5% horse blood agar and chocolate agar plates, and the concentration of bacteria was determined by quantitative culture (10-fold serial dilutions from 10-1 to 10-10). Strains were identified by colony morphology, oxidase reaction, and results of the API 20 E system (bioMérieux).
From a 0.5-ml aliquot of blood, template DNA was prepared by using a simple and rapid boiling procedure, taking less than 20 min [16, 17]. Briefly, the aliquot was centrifuged at 850 × g for 2 min to remove the charcoal. The supernatant was centrifuged at 11,500 × g for 5 min. The resulting pellet was resuspended in 200 μl of a lysis buffer containing 1% Triton X-100, 0.5% Tween 20, 10 mM Tris-Hcl (pH 8.0), and 1 mM EDTA and incubated at 100°C for 10 min. After centrifugation for 2 min at 850 × g, the supernatant was directly used for PCR.
Oligonucleotide primers and LightCycler hybrizidation probes used in the PCR assay
Limit of detection
A plasmid standard curve was constructed by ligating the 152-bp PCR product from P. aeruginosa ATCC 27853 into the commercial plasmid vector, pCR2.1-TOPO plasmid vector from the TOPO TA Cloning Kit (Invitrogen, Cergy-Pontoise, France) following the manufacturer's recommendations to produce plasmid pRT-ecfX. This plasmid was transformed into competent TOP10 Escherichia coli cells (Invitrogen), and transformants were selected on media containing 30 μg/mL kanamycin. Plasmid DNA was extracted and purified from one transformant using the HiSpeed Midi Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions, resuspended in elution buffer (Qiagen) and sequenced to determine the presence of the ecfX insert and its orientation. Plasmid DNA concentration was determined by using the NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Illkirch, France), and the plasmid DNA reference material was then serially diluted to obtain 10 to 1010 plasmid genome equivalents for standard curve analysis. Quantitative analysis was carried out with the LightCycler software version 3.5 (Roche). The ratio of signals measured at 705 nm/signals measured at 530 nm was used to calculate the crossing point values.
ecfX qPCR testing of P. aeruginosa from 98 positive blood culture bottles
No. of samples detected
Total no. of samples
E. coli + Klebsiella oxytocaa
E. cloacae + K. oxytocaa
K. pneumoniae + P. aeruginosaa, b
Even if the motility in an aerobic bottle may be a good predictive value of P. aeruginosa isolation, the observation of non-motile rods or atypical motility is regularly observed  as well as the growth of this aerobe in anaerobic bottles (6% in our study) . By comparison with the new FDA-approved technique (i.e. fluorescence in situ hybrizidation with peptide nucleic acid probes) directly used on positive BCs, this novel qPCR method showed similar performances but appeared faster (1.5 h vs 2.5 h) [20, 21]. Nevertheless, a limit of the qPCR technique is the potential presence of PCR inhibitors (e.g. charcoal, haemoglobin) in BC specimens.
The timely and accurate information provided by this qPCR assay would help clinicians identify P. aeruginosa bacteremia, and thereby initiate adequate antimicrobial therapy 18 to 24 h earlier than would be possible with conventional methods, as previously described for Staphylococcus aureus[16, 17] and K. pneumoniae. However, as opposed to S. aureus and methicillin resistance, it is difficult to predict an useful antibiotic susceptibility profile of P. aeruginosa by molecular techniques even if it is possible to detect several resistance genes such as emerging carbapenemase genes . Indeed, the choice of antibiotic treatment has to consider national and local epidemiology since multidrug resistant P. aeruginosa isolates are increasingly reported worldwide . Therefore, in order to minimize the risk of inappropriate treatment, the use of combination antimicrobial therapy, until susceptibility results become known, may be preferable in certain situations [5, 6].
As a conclusion, we developed a promising qPCR technique that offers a fast (<1.5 h) tool with high sensitivity and specificity for the identification of P. aeruginosa from positive BCs. Further investigations will be perform to evaluate the clinical impact of this novel strategy as compared to conventional methods.
- Driscoll JA, Brody SL, Kollef MH: The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007, 67: 351-368. 10.2165/00003495-200767030-00003View ArticlePubMedGoogle Scholar
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39: 309-317. 10.1086/421946View ArticlePubMedGoogle Scholar
- Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ, et al.: Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 2009, 48: 580-586. 10.1086/596709View ArticlePubMedGoogle Scholar
- Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW: Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003, 37: 745-751. 10.1086/377200View ArticlePubMedGoogle Scholar
- Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH: Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005, 49: 1306-1311. 10.1128/AAC.49.4.1306-1311.2005PubMed CentralView ArticlePubMedGoogle Scholar
- van Delden C: Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents 2007,30(Suppl 1):S71-75. 10.1016/j.ijantimicag.2007.06.015View ArticlePubMedGoogle Scholar
- Procop GW: Molecular diagnostics for the detection and characterization of microbial pathogens. Clin Infect Dis 2007,45(Suppl 2):S99-S111. 10.1086/519259View ArticlePubMedGoogle Scholar
- De Vos D, Lim A Jr, Pirnay JP, Struelens M, Vandenvelde C, Duinslaeger L, Vanderkelen A, Cornelis P: Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL . J Clin Microbiol 1997, 35: 1295-1299.PubMed CentralPubMedGoogle Scholar
- Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL: Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 2003, 41: 4312-4317. 10.1128/JCM.41.9.4312-4317.2003PubMed CentralView ArticlePubMedGoogle Scholar
- da Silva Filho LV, Tateno AF, Velloso Lde F, Levi JE, Fernandes S, Bento CN, Rodrigues JC, Ramos SR: Identification of Pseudomonas aeruginosa , Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR. Pediatr Pulmonol 2004, 37: 537-547. 10.1002/ppul.20016View ArticlePubMedGoogle Scholar
- Lavenir R, Jocktane D, Laurent F, Nazaret S, Cournoyer B: Improved reliability of Pseudomonas aeruginosa PCR detection by the use of the species-specific ecfX gene target. J Microbiol Methods 2007, 70: 20-29. 10.1016/j.mimet.2007.03.008View ArticlePubMedGoogle Scholar
- Motoshima M, Yanagihara K, Fukushima K, Matsuda J, Sugahara K, Hirakata Y, Yamada Y, Kohno S, Kamihira S: Rapid and accurate detection of Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis targeting gyrB gene. Diagn Microbiol Infect Dis 2007, 58: 53-58. 10.1016/j.diagmicrobio.2006.11.007View ArticlePubMedGoogle Scholar
- Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE, Nissen MD, Sloots TP: Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 2009, 63: 127-131. 10.1016/j.diagmicrobio.2008.09.018View ArticlePubMedGoogle Scholar
- Jaffe RI, Lane JD, Bates CW: Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J Clin Lab Anal 2001, 15: 131-137. 10.1002/jcla.1016View ArticlePubMedGoogle Scholar
- Kurupati P, Kumarasinghe G, Laa Poh C: Direct identification of Pseudomonas aeruginosa from blood culture bottles by PCR-enzyme linked immunosorbent assay using oprI gene specific primers. Mol Cell Probes 2005, 19: 417-421. 10.1016/j.mcp.2005.07.005View ArticlePubMedGoogle Scholar
- Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N: Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol 2000, 38: 2429-2433.PubMed CentralPubMedGoogle Scholar
- Shrestha NK, Tuohy MJ, Hall GS, Isada CM, Procop GW: Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ALERT blood culture bottles by using the LightCycler system. J Clin Microbiol 2002, 40: 2659-2661. 10.1128/JCM.40.7.2659-2661.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Schonheyder HC, Pedersen G: Pseudomonas aeruginosa bacteraemia detected with a new blood culture system Colorbact: a note of caution. Apmis 1993, 101: 732-734. 10.1111/j.1699-0463.1993.tb00173.xView ArticlePubMedGoogle Scholar
- Enoch DA, Simpson AJ, Kibbler CC: Predictive value of isolating Pseudomonas aeruginosa from aerobic and anaerobic blood culture bottles. J Med Microbiol 2004, 53: 1151-1154. 10.1099/jmm.0.45727-0View ArticlePubMedGoogle Scholar
- Sogaard M, Stender H, Schonheyder HC: Direct identification of major blood culture pathogens, including Pseudomonas aeruginosa and Escherichia coli , by a panel of fluorescence in situ hybridization assays using peptide nucleic acid probes. J Clin Microbiol 2005, 43: 1947-1949. 10.1128/JCM.43.4.1947-1949.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Peleg AY, Tilahun Y, Fiandaca MJ, D'Agata EM, Venkataraman L, Moellering RC, Eliopoulos GM: Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa . J Clin Microbiol 2009, 47: 830-832. 10.1128/JCM.01724-08PubMed CentralView ArticlePubMedGoogle Scholar
- Kurupati P, Chow C, Kumarasinghe G, Poh CL: Rapid detection of Klebsiella pneumoniae from blood culture bottles by real-time PCR. J Clin Microbiol 2004, 42: 1337-1340. 10.1128/JCM.42.3.1337-1340.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Nordmann P, Naas T, Fortineau N, Poirel L: Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus , Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol 2007, 10: 436-440. 10.1016/j.mib.2007.07.004View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.